trial · primary record
Tirabrutinib
Relapsed/Refractory Primary Central Nervous System Lymphoma
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 132 |
| Primary completion | 2029-12 |
| Primary endpoint | Progression Free Survival (PFS) |
| Registry ID | NCT07104032 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:50.884Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07104032
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.